These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents. Vadhan-Raj S Semin Hematol; 2009 Jan; 46(1 Suppl 2):S26-32. PubMed ID: 19245931 [TBL] [Abstract][Full Text] [Related]
23. Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura. Zhang Y; Kolesar JM Clin Ther; 2011 Nov; 33(11):1560-76. PubMed ID: 22054810 [TBL] [Abstract][Full Text] [Related]
24. Two new drugs for chronic ITP. Med Lett Drugs Ther; 2009 Feb; 51(1305):10-1. PubMed ID: 19197233 [TBL] [Abstract][Full Text] [Related]
25. Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV - the role of epoetin, G-CSF and novel agents. Mac Nicholas R; Norris S Aliment Pharmacol Ther; 2010 May; 31(9):929-37. PubMed ID: 20175767 [TBL] [Abstract][Full Text] [Related]
26. Eltrombopag: How secure in triple therapy of HCV? Kayar Y; Danalioglu A; Kocaman O; Baysal B; Senturk H Acta Gastroenterol Belg; 2015 Dec; 78(4):445-6. PubMed ID: 26712061 [TBL] [Abstract][Full Text] [Related]